1Associate Professor, Department of Pediatrics, PGIMS, Rohtak
2Senior Professor, Department of Pediatrics, PGIMS, Rohtak
3Associate Professor, Department of Forensic Medicine, PGIMS, Rohtak
4Assistant Professor, Department of Pediatrics, PGIMS, Rohtak
5Professor, Deptt. of ENT, PGIMS, Rohtak
6Junior Resident, Department of Pediatrics, PGIMS, Rohtak
*Corresponding author: Dr. Alok Khanna Associate Professor, 8/8FM, PGIMS Campus, Rohtak Email: vj78@live.in
Online published on 4 January, 2017.
The purpose of the study was to evaluate the efficacy of levamisole in children suffering from primary nephrotic syndrome (NS) who were steroid dependent (SDNS) or frequently relapsing (FRNS). It was observed that addition of levamisole to alternate day prednisolone therapy and continuing it after the prednisolone therapy was stopped significantly reduced the relapse rate. This also resulted in significantly reduced use of corticosteroids. There were minimal side effects due to levamisole. It is therefore concluded that levamisole reduces the incidence of relapses. This results in more disease free life and less steroid requirements.
Nephrotic Syndrome, Levamisole, Steroid, Relapses